The effect of inorganic arsenic on endothelium-dependent relaxation: Role of NADPH oxidase and hydrogen peroxide by Edwards, David Hughes et al.
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Chronic  arsenic  ingestion  predisposes  to vascular  disease,  but  underlying  mechanisms  are  poorly  under-
stood. In  the  present  study  we have  analyzed  the effects  of  short-term  arsenite  exposure  on vascular
function  and  endothelium-dependent  relaxation.
Endothelium-dependent  relaxations,  nitric  oxide  (NO)  and  endothelium  derived  hyperpolarizing  factor
(EDHF)-type,  were  studied  in rabbit  iliac  artery  and  aortic  rings  using  the  G protein-coupled  receptor
agonist  acetylcholine  (ACh)  and  by  cyclopiazonic  acid  (CPA),  which  promotes  store-operated  Ca2+ entry  by
inhibiting  the  endothelial  SERCA  pump.  Production  of  reactive  oxygen  species  (ROS)  in the  endothelium
of  rabbit  aortic  valve  leaﬂets  and  endothelium-denuded  RIA  and  aortic  rings  was  assessed  by  imaging  of
dihydroethidium.
In the  iliac  artery,  exposure  to 100  M arsenite  for 30  min  potentiated  EDHF-type  relaxations  evoked  by
both  CPA  and  ACh.  Potentiation  was prevented  by  catalase,  the  catalase/superoxide  dismutase  mimetic
manganese  porphyrin  and  the  NADPH  oxidase  inhibitor  apocynin.  By  contrast  in  aortic  rings,  that  exhib-
ited  negligible  EDHF-type  responses,  endothelium-dependent  NO-mediated  relaxations  evoked  by CPA
and ACh  were  unaffected  by  arsenite.  Arsenite  induced  apocynin-sensitive  increases  in  ROS  production
in the  aortic  valve  endothelium,  but  not  in  the  media  and  adventitia  of the iliac  artery  and aorta.
Our  results  suggest  that arsenite  can  potentiate  EDHF-type  relaxations  via  a  mechanism  that  is  depend-
ent  on hydrogen  peroxide,  thus  demonstrating  that  dismutation  of  the  superoxide  anion  generated  by
NADPH  oxidase  can  potentially  offset  loss  of  NO bioavailability  under  conditions  of reduced  eNOS  activ-
ity. By  contrast,  selective  increases  in  endothelial  ROS  production  following  exposure  to arsenite  failed
diateto modify  relaxations  me
. Introduction
In the cardiovascular system, exposure to arsenic accelerates the
evelopment of atherosclerosis and predisposes to hypertension
nd peripheral microvascular abnormalities such as Blackfoot Dis-
ase (Balakumar and Kaur, 2009; Prozialeck et al., 2008; States et al.,
009). Underlying mechanisms have been suggested to involve
ncreased oxidant stress, because exposure of endothelial cells
o arsenite at concentrations within the range found in contam-
nated drinking water (0.3–15 M)  causes excess production of
he superoxide anion (O2•−) by nicotinamide adenine dinucleotide
Abbreviations: ACh, acetylcholine; CPA, cyclopiazonic acid; DHE, dihydroethid-
um; ER, endoplasmic reticulum; KCa, calcium-activated K+ channels; NO, nitric
xide; H2O2, hydrogen peroxide; L-NAME, NG-nitro-L-arginine methyl ester; O2•− ,
uperoxide anion; PE, phenylephrine; RIA, rabbit iliac artery; ROS, reactive oxygen
pecies; SOD, superoxide dismutase.
∗ Corresponding author. Tel.: +44 2920 742913; fax: +44 2920 743500.
E-mail address: edwardsdh@cardiff.ac.uk (D.H. Edwards).
300-483X/$ – see front matter ©  2013 Elsevier Ireland Ltd. All rights reserved.
ttp://dx.doi.org/10.1016/j.tox.2013.01.019d  by  endogenous  NO.
© 2013 Elsevier Ireland Ltd. All rights reserved.
phosphate (NADPH) oxidase (Barchowsky et al., 1999; Smith et al.,
2001; Qian et al., 2005; Straub et al., 2008). O2•− may contribute to
vascular dysfunction through a rapid interaction with, and inacti-
vation of, the potent vascular relaxing factor endothelium-derived
nitric oxide (NO) (Lassègue and Griendling, 2010). Dismutation
of O2•− by superoxide dismutase (SOD) also generates hydro-
gen peroxide (H2O2), and the production of both reactive oxygen
species (ROS) increases within minutes of exposing endothelial
cells to low concentrations of arsenite (5 M)  (Barchowsky et al.,
1999; Smith et al., 2001). Notably, endothelium-derived H2O2
is now thought to participate in the physiological response to
endothelium-dependent agonists and ﬂuid shear stress (Matoba
et al., 2002; Liu et al., 2011), and can compensate for the loss of NO
bioavailability observed in experimental models of hypertension
and diabetes and in patients with arterial disease (Karasu, 2000;
Landmesser et al., 2003; Phillips et al., 2007; Larsen et al., 2009). One
possible mode of action may  be an ability of H2O2 to relax subjacent
smooth muscle cells by acting as a freely diffusible endothelium-
derived hyperpolarizing factor (EDHF) (Matoba et al., 2002; Liu
et al., 2011). However, H2O2 may  also promote depletion of the
oxicology 306 (2013) 50– 58 51
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Table 1
Effects of exposure to arsenite for 30 min on endothelium-dependent relaxations to
CPA  and ACh in the iliac artery.
CPA n pIC50 Rmax,  %
Control 9 4.99 ± 0.07 94.4 ± 2.8
Arsenite 100 M 4.98 ± 0.10 91.6 ± 3.3
L-NAME + indo 6 4.76 ± 0.07 82.7 ± 3.9
L-NAME + indo + arsenite 30 M 4.85 ± 0.05 79.8 ± 3.3
L-NAME + indo 22 4.85 ± 0.05 82.1 ± 1.8
L-NAME + indo + arsenite 100 M 5.16 ± 0.08*** 83.1 ± 1.7
ACh n pEC50 Rmax,  %
Control 12 7.32 ± 0.10 91.3 ± 2.2
Arsenite 100 M 7.52 ± 0.10 91.1 ± 2.3
L-NAME + indo 12 6.83 ± 0.09 72.7 ± 4.1
L-NAME + indo + arsenite 100 M 7.08 ± 0.09*** 72.4 ± 4.0
Experiments were performed in the absence (control) and presence of L-NAME
(300 M)  and indomethacin (10 M).  Potency (negative log IC50 or log EC50) and
maximal responses (R ) are given as mean ± SEM. n denotes the number of animalsD.H. Edwards et al. / T
ndothelial endoplasmic reticulum (ER) Ca2+ store and amplify
ncreases in cytosolic Ca2+ evoked by pharmacological stimulation
f the endothelium (Hu et al., 2000; Edwards et al., 2008). This
ynergy can enhance the opening of calcium-activated K+ channels
KCa) thereby allowing H2O2 to potentiate “EDHF-type” relaxations
hat are mediated by the spread of endothelial hyperpolariza-
ion into the arterial media via myoendothelial and homocellular
mooth muscle gap junctions (Edwards et al., 2008; Garry et al.,
009). Recently it has been reported that EDHF-type responses
o the endocannabinoid-like molecule N-oleoylethanolamine are
odulated by H2O2 (Wheal et al., 2012).
The aim of the current study was to investigate how inor-
anic AsIII, which is intrinsically more toxic than inorganic AsV
Vahter, 2002), affects EDHF-type and NO-mediated relaxations via
he generation of O2•− and H2O2. Endothelium-dependent relax-
tions of rabbit iliac artery (RIA) and aortic rings were elicited
y the G protein-coupled receptor agonist acetylcholine (ACh)
nd by cyclopiazonic acid (CPA), which promotes store-operated
a2+ entry by depleting ER Ca2+ by inhibiting the endothe-
ial SERCA pump (Fernandez-Rodriguez et al., 2009). In the RIA
uch relaxations consist of dual NO-mediated and EDHF-type
ap junction-dependent components (Grifﬁth et al., 2004, 2005;
haytor et al., 2005), whereas in the aorta the EDHF-type compo-
ent is negligible, so that the two mechanisms of relaxation can
e dissociated (Ruiz et al., 1997; Fernandez-Rodriguez et al., 2009).
he effects of arsenite were compared in the presence and absence
f endogenous NO production, and the functional role of H2O2
nvestigated with catalase and a manganese-based SOD/catalase
imetic (Day et al., 1997). The role of NADPH oxidase was investi-
ated with apocynin, which blocks the assembly of speciﬁc forms
f this enzyme, and prevents the generation of O2•− and H2O2 in
ultured endothelial cells treated with arsenite (Barchowsky et al.,
999; Touyz, 2008). Dihydroethidium (DHE) was used to assess ROS
roduction in the different layers of the arterial wall (Zielonka and
alyanaraman, 2010).
. Methods
.1. Mechanical responses
Iliac arteries, aortae and aortic valve leaﬂets (RAV) were obtained from male
ZW rabbits (2–2.5 kg) killed by injection of sodium pentobarbital (150 mg/kg;
.v.)  via the marginal ear vein and in accordance with local University guide-
ines. Rings of iliac artery or aorta 2–3 mm wide were mounted in a myograph
model 610M, Danish Myotechnology, Aarhus, Denmark) containing oxygenated
95% O2; 5% CO2) Holman’s buffer (composition in mM:  NaCl 120, KCl 5, NaH2PO4
.3, NaHCO3 25, CaC12 2.5, glucose 11, and sucrose 10) at 37 ◦C and maintained
t a resting tension of 1 mN over a 60 min  equilibration period, with frequent
eadjustments in baseline tension to correct for stress relaxation. To evaluate
DHF-type responses, preparations were incubated for 30 min  with the eNOS
nhibitor NG-nitro-L-arginine methyl ester (L-NAME, 300 M)  and the cyclooxy-
enase inhibitor indomethacin (10 M)  to inhibit prostanoid formation. Sodium
rsenite (30 or 100 M)  was then added for 30 or 90 min prior to constriction
ith phenylephrine (PE, 1 M).  Once constrictor responses had reached a stable
lateau, relaxation was studied by constructing cumulative concentration–response
urves to CPA or ACh in the continued presence of arsenite. These curves were
enerally completed within ∼60 min  so that total cumulative exposure to arsenite
as  90 min  and 150 min  in the two protocols. Preliminary experiments demon-
trated that lower concentrations of arsenite (10 M)  did not affect relaxation
nder these experimental conditions. To evaluate the role of O2•− and H2O2,
atalase (2000 units/ml, from bovine liver), manganese(III) tetrakis (1-methyl-4-
yridyl) porphyrin (MnTMPyP, 100 M)  or the NADPH oxidase inhibitor apocynin
1-(4-hydroxy-3-methoxyphenyl)ethanone, 100 M)  were co-administered with L-
AME and indomethacin.
.2. Detection of superoxide/hydrogen peroxideRAV leaﬂets, and endothelium-denuded rings of iliac artery and aorta were
ncubated with arsenite (100 M),  apocynin (100 M)  or both for 60 min  in oxy-
enated Holman’s buffer containing L-NAME (300 M)  and indomethacin (10 M)
t  37 ◦C. To assess the production of reactive oxygen species (ROS) dihydroethidium
DHE, 5 M)  was  then added for a further 30 min, following which the preparationsmax
studied.
*** P < 0.001 compared with time-matched preparations not exposed to arsenite.
were washed and ﬁxed in 4% paraformaldehyde and images collected with a Leica
SP5 confocal microscope (excitation 514 nm,  emission 560–630 nm). This proto-
col  was  designed to match the total exposure of rings preincubated with 100 M
arsenite for 30 min  in mechanical experiments in which it took a further ∼60 min
to  construct full concentration–relaxation curves. It should be noted that oxida-
tion of DHE can generate two products, ethidium and 2-hydroxyethidium, which
possess overlapping emission spectra and whose ﬂuorescence is enhanced by bind-
ing to DNA (Zielonka and Kalyanaraman, 2010). Although H2O2 does not oxidize
DHE  directly and the formation of 2-hydroxyethidium is speciﬁc for O2•− , H2O2
may  promote the formation of ethidium in the presence of peroxidase activity or
haem proteins so that increased ﬂuorescence in DHE-loaded vascular smooth mus-
cle/endothelial cells may  reﬂect production of both O2•− and H2O2 (Fernandes et al.,
2007; Ray et al., 2011). The RAV was  used to circumvent the complicating effects of
signals transmitted from subjacent smooth muscle to the endothelium. All imaging
data presented were acquired in the presence of L-NAME in order to avoid poten-
tially confounding effects of NO which has been reported to promote the formation
of  ethidium in the presence of molecular oxygen (Zielonka and Kalyanaraman,
2010).
2.3. Statistics
The maximal percentage reversal of PE-induced tone (Rmax) by CPA or ACh and
concentrations giving 50% reversal of this constrictor response (IC50 for CPA) or 50%
of  maximal relaxation (EC50 for ACh) were determined for each experiment. The use
of  IC50 rather than EC50 was necessary to allow for small initial constrictor responses
to  CPA that were observed in many experiments and can be attributed to an effect
of CPA on smooth muscle Ca2+ stores (Chaytor et al., 2005). All metrics are given
as  mean ± SEM and compared using paired or unpaired Student’s t-tests or one-
way ANOVA followed by a Bonferroni’s post-test as appropriate. Signiﬁcance was
accepted at P < 0.05; n denotes the number of animals studied in each experimental
group.
2.4. Reagents
Pharmacological agents were purchased from Sigma–Aldrich (UK), except CPA
(Ascent Scientiﬁc) and MnTMPyP (Calbiochem), and were dissolved in Holman’s
buffer, except apocynin and indomethacin (absolute ethanol), and CPA and DHE
(DMSO).
3. Results
3.1. Effects of arsenite on responses to CPA and ACh in the RIA
3.1.1. EDHF-type relaxations
Responses evoked by CPA in the presence of L-
NAME/indomethacin were unaffected by exposure to 30 M
arsenite for 30 min, whereas exposure to 100 M arsenite for
30 min  caused a leftward shift in the concentration–relaxation
curve, such that pIC50 increased from ∼4.8 to ∼5.2 without change
in Rmax (Fig. 1A; Table 1). EDHF-type relaxations evoked by ACh
were similarly potentiated by exposure to 100 M arsenite for
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Fig. 1. Effects of arsenite on EDHF-type relaxations in endothelium-intact iliac artery rings. (A) Concentration–response curves and original recordings showing that 100 M
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(Fig. 3A). Rmax and pIC50/pEC50 values for concentration–relaxation
curves constructed for CPA and ACh were unaffected by incuba-
tion with 100 M arsenite for 30 min (Table 2). As in the RIA, thisrsenite, but not 30 M,  potentiated CPA-evoked EDHF-type relaxations after 30 m
voked  by ACh. Rings were constricted by 1 M phenylephrine (PE). n denotes the 
0 min, exhibiting a signiﬁcant increase in pEC50 from ∼6.8 to ∼7.0
ithout change in Rmax (Fig. 1B; Table 1).
.1.2. EDHF-type/NO-mediated relaxations
In control rings with intact endothelium incubated in the
bsence of L-NAME/indomethacin, the additional contribution
f NO to CPA- and ACh-evoked relaxations was evidenced by
IC50 values of ∼5.0 and ∼7.3, and increases in Rmax to ∼90%
rom ∼80% and ∼70% compared to the corresponding EDHF-type
oncentration–relaxation curves (Table 1). Responses to CPA and
Ch were unaffected by incubation with 100 M arsenite for 30 min
Fig. 2A and B; Table 1).
.1.3. Contraction
In control rings incubated in the absence of L-
AME/indomethacin, the magnitude of the constrictor response
o 1 M PE was unaffected by exposure to 30 M arsenite
or 30 min, but was reduced by ∼15% following exposure to
00 M arsenite for 30 min  (from 30.1 ± 1.7 mN  to 26.7 ± 1.8 mN,
ooled data from all experiments n = 21, P < 0.01). Incubation
ith L-NAME/indomethacin increased PE-induced constriction
y ∼15% and this increment in tone was reversed by expo-
ure to 100 M arsenite for 30 min  (from 35.3 ± 1.2 mN  to
0.0 ± 1.1 mN,  pooled data from all experiments n = 73, P < 0.01),
uch that constriction then matched the level observed in the
bsence of L-NAME/indomethacin. No attempt was  made to
orrect for these small overlapping effects on pre-relaxation
one.) Exposure to 100 M arsenite for 30 min also potentiated EDHF-type relaxations
er of animals studied.
3.2. Effects of arsenite on NO-mediated aortic relaxation
Maximal relaxations evoked by CPA and ACh in aortic rings
with intact endothelium were equivalent to ∼70% of PE-induced
tone and were mediated by NO because no signiﬁcant EDHF-type
component was evident in the presence of L-NAME/indomethacinFig. 2. Concentration–response curves showing that exposure to 100 M arsenite
for 30 min  did not affect endothelium-dependent relaxations evoked by CPA or ACh
in  the iliac artery in the absence of L-NAME/indomethacin. n denotes the number of
animals studied.
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Fig. 3. Effects of arsenite on relaxation in aortic rings with intact endothelium. (A) EDHF-ty
in  this vessel can be attributed to NO. (B) Concentration–relaxation curves for CPA and ACh
to  100 M arsenite for 30 min. n denotes the number of animals studied.
Table 2
Effects of exposure to 100 M arsenite for 30 min  on endothelium-dependent relax-
ations to CPA and ACh in the aorta.
CPA n pIC50 Rmax, %
Control 6 4.73 ± 0.24 82.4 ± 1.7
Arsenite 5.00 ± 0.12 78.1 ± 4.1
ACh n pEC50 Rmax, %
Control 8 7.09 ± 0.03 63.0 ± 1.2
Arsenite 7.19 ± 0.07 69.5 ± 2.5
Potency (negative log IC50 or log EC50) and maximal responses (Rmax) are given as
mean ± SEM. n denotes the number of animals studied.
Fig. 4. Inhibitory effects of (A) 2000 units/ml catalase, (B) 100 M MnTMPyP, and (C) 100 
to  100 M arsenite for 30 min. n denotes the number of animals studied.pe relaxations were <5% of induced tone so that endothelium-dependent relaxation
 constructed in the absence of L-NAME/indomethacin were unaffected by exposure
incubation protocol reduced PE-induced constriction by ∼15%
(from 26.9 ± 1.6 mN to 22.9 ± 1.3 mN,  pooled data from all experi-
ments n = 14, P < 0.01).
3.3. Effects of catalase, manganese porphyrin and apocynin on
EDHF-type responses to CPA in the RIA
To investigate the mechanisms responsible for the selective
potentiation of relaxations elicited in the presence of L-
NAME/indomethacin, rings were preincubated with 2000 units/ml
catalase, 100 M MnTMPyP or 100 M apocynin (Fig. 4). None of
these agents alone signiﬁcantly affected pIC50 and Rmax values for
M apocynin on the potentiation of CPA-evoked EDHF-type relaxations by exposure
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Table 3
Effects of catalase, MnTMPyP and apocynin on the potentiation of CPA-evoked EDHF-
type  relaxations in the iliac artery by 100 M arsenite for 30 min.
CPA n pIC50 Rmax, %
L-NAME + indo 9 4.92 ± 0.05 79.5 ± 2.3
+  Arsenite 100 M 5.21 ± 0.07*** 81.0 ± 2.5
+  Catalase 2000 U ml−1 4.79 ± 0.05 82.2 ± 2.8
+  Arsenite + catalase 4.80 ± 0.04 77.9 ± 3.0
L-NAME + indo 8 4.68 ± 0.07 78.9 ± 2.8
+  Arsenite 100 M 5.05 ± 0.05* 84.1 ± 3.1
+  MnTMPyP 100 M 4.59 ± 0.07 73.3 ± 4.5
+  Arsenite + MnTMPyP 4.69 ± 0.10 70.7 ± 5.6
L-NAME + indo 14 4.99 ± 0.07 86.2 ± 1.9
+  Arsenite 100 M 5.31 ± 0.05** 83.1 ± 2.1
+  Apocynin 100 M 4.89 ± 0.07 78.7 ± 3.7
+  Arsenite + apocynin 5.04 ± 0.06 82.9 ± 3.1
All experiments were performed in the presence of L-NAME (300 M) and
indomethacin (10 M).  Potency (negative log IC50) and maximal responses (Rmax)
are given as means ± SEM. n denotes the number of animals studied.
*
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Table 4
Effects of exposure to 100 M arsenite for 90 min  on endothelium-dependent relax-
ations to ACh and direct relaxation to MAHMA  NONOate in the RIA.
ACh n pEC50
Control 7 7.11 ± 0.06
Arsenite 7 7.37 ± 0.14
L-NAME + indo 9 6.74 ± 0.09
L-NAME + indo + arsenite 9 7.03 ± 0.13
MAHMA  NONOate n pEC50
1 M PE, L-NAME + indo 17 7.01 ± 0.11
1  M PE, L-NAME + indo + arsenite 11 7.02 ± 0.15
0.1  M PE, L-NAME + indo 6 7.39 ± 0.11
F
f
nP < 0.05 compared with time-matched controls.
** P < 0.01 compared with time-matched controls.
*** P < 0.001 compared with time-matched controls.
elaxation in the absence of arsenite, whereas the enhancement
f relaxation observed following exposure to 100 M arsenite for
0 min  was fully prevented in each case (Table 3).
.4. Fluorescence imaging of ROS productionExposure to 100 M arsenite for 90 min  signiﬁcantly enhanced
ndothelial nuclear ﬂuorescence in RAV leaﬂets loaded with DHE in
he presence of L-NAME/indomethacin, an effect that was fully pre-
ented by preincubation with 100 M apocynin (Fig. 5). Exposure
ig. 5. Endothelial ROS production in rabbit isolated aortic valve leaﬂets loaded with D
ollowing exposure to 100 M arsenite for 90 min, but was  unaffected by apocynin or arsen
 denotes the number of animals studied.Potency (negative log EC50) is given as mean ± SEM. n denotes the number of animals
studied.
to 100 M arsenite for 90 min  did not increase ﬂuorescence in
either the media or adventitia of endothelium-denuded RIA and
aortic rings loaded with DHE (Fig. 6).
3.5. Effects of longer term exposure to arsenite
Exposure to 100 M arsenite for 90 min  caused a ∼30% reduc-
tion in force development in RIA rings constricted by 1 M PE
from 33.9 ± 2.9 mN to 23.5 ± 2.6 mN (n = 26 and 20) in the presence
of L-NAME/indomethacin and from 30.9 ± 5.4 mN  to 22.4 ± 5.3 mN
(n = 9 and 9) in control rings (pooled data from Fig. 7; P < 0.01
in each case). This large depressor effect affected the analysis of
endothelium-dependent relaxation, because absolute tension ulti-
mately converged to a similar plateau in the presence and absence
of arsenite at the highest concentrations of ACh. Consequently, nor-
malization to initial pre-relaxation tone led to an apparent decrease
HE in the presence of L-NAME/indomethacin. (A) Nuclear ﬂuorescence increased
ite in combination with apocynin. (B) Bar graphs conﬁrming statistical signiﬁcance.
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Fig. 6. Fluorescence studies of endothelium-denuded iliac artery and aortic rings
loaded with DHE in the presence of L-NAME/indomethacin. (A) and (B) Images and
bar  graphs showing that neither artery type exhibited evidence of excess ROS pro-
duction in the media of the vessel wall following exposure to 100 M arsenite for
90  min. The adventitia of both vessels displayed autoﬂuorescence, but its appear-
ances were unaltered by exposure to arsenite. Scalebars identify the vessel lumen.
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Fig. 7. Effects of 90 min exposure to 100 M arsenite on relaxation in endothelium-
intact iliac artery rings. Data are presented as absolute reversal (left panels) and
%  reversal (right panels) of PE-induced constriction. (A) EDHF-type responses to
ACh.  (B) Responses to ACh with L-NAME/indomethacin omitted from the buffer. (C) denotes the number of animals studied.
n Rmax on a % basis (Fig. 7A and B), whereas pEC50 values derived
rom the concentration–relaxation curves were unaffected by arse-
ite (Table 4).
Similar experiments demonstrated that exposure to 100 M
rsenite for 90 min  also impaired smooth muscle relaxations to the
xogenous NO donor MAHMA  NONOate in endothelium-intact RIA
ings incubated with L-NAME/indomethacin. The use of an exoge-
ous NO donor excludes any potential effect of arsenite on the NO
ynthase pathway. Again this incubation protocol did not statis-
ically affect pEC50 values derived from concentration–relaxation
urves, whereas Rmax was reduced (Fig. 7C; Table 4).
Experiments were also performed in which the relaxant effects
f arsenite on pre-relaxation tone were mimicked by reducing the
oncentration of PE used to induce constriction to 0.1 M (Fig. 7C).
max and pEC50 values for MAHMA  NONOate were then larger than
n experiments conducted in the presence of 1 M PE or 1 M
E plus 100 M arsenite, as complete relaxation was obtained
n the presence of the lower concentration of 0.1 M PE (Fig. 7;
able 4).
. Discussion
The present study has provided new insights into the mech-
nisms through which short-term exposure to inorganic arsenic
an modulate endothelial, and therefore vascular, function. Arse-
ite was shown to potentiate EDHF-type relaxations by stimulating
ndothelial NADPH oxidase activity and thereby promoting the
ormation of H2O2 from O2•−, whereas relaxations mediated by
ndothelium-derived NO were unaffected.Responses to MAHMA  NONOate in the presence of L-NAME/indomethacin.
4.1. Potentiating effects of arsenite on the EDHF phenomenon
Arsenite ampliﬁed EDHF-type relaxations evoked by the SERCA
inhibitor CPA in RIA rings in a concentration-dependent manner,
with potentiation being apparent following exposure to 100 M,
but not 30 M,  arsenite for 30 min. This potentiation was prevented
by catalase and the catalase/SOD mimetic MnTMPyP, thus con-
ﬁrming a central role for endogenously generated H2O2. Enhanced
relaxation was also prevented by apocynin, and this NADPH oxidase
inhibitor abolished arsenite-induced increases in ﬂuorescence in
RAV leaﬂets loaded with the ROS sensitive probe DHE. Arsenite sim-
ilarly enhanced EDHF-type relaxations to ACh, although this effect
was less prominent than with CPA, consistent with previous obser-
vations that exogenous H2O2 ampliﬁes EDHF-type relaxations to
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Ch at a higher threshold compared with CPA (Garry et al., 2009).
aken together, these ﬁndings indicate that excess O2•− generated
y the activation of endothelial NADPH oxidase by arsenite can
erve as a source of H2O2 that modulates the EDHF phenomenon.
revious analysis has demonstrated that exogenous H2O2 synergis-
ically enhances depletion of the ER Ca2+ store by CPA and ampliﬁes
lectrotonically conducted relaxations by promoting endothelial
Ca channel opening (Edwards et al., 2008; Garry et al., 2009). The
resent study extends these observations by demonstrating that
ndogenously generated H2O2 can enhance the biological role of
he EDHF phenomenon under conditions of increased oxidative
tress.
The classical phagocytic NADPH oxidase comprises a
embrane-bound ﬂavocytochrome b558 component constructed
rom a catalytic Nox subunit (designated as Nox2 or gp91phox)
nd a p22phox regulatory subunit. p22phox co-activation requires
ranslocation of additional protein subunits (p47phox, p67phox,
40phox and the small GTPase Rac1) to the cell membrane where
hey associate with the b558 heterodimer in a cascade that can be
nterrupted by apocynin at the level of p47phox (Ray and Shah,
005; Touyz, 2008; Lassègue and Griendling, 2010). Exposure to
rsenite increases the overall Nox catalytic activity of membrane
ractions from cultured intact endothelial cells by twofold within
 h, whereas treatment of isolated endothelial membranes is
ithout effect (Smith et al., 2001). More speciﬁcally, the ability of
rsenite to stimulate endothelial O2•− production has an obliga-
ory requirement for gp91phox, p47phox and p67phox and Rac1,
onsistent with activation of the Nox2-based oxidase (Smith et al.,
001; Qian et al., 2005; Straub et al., 2008). It should be noted
hat the Nox2-based oxidase can also be detected in a perinuclear
istribution where it is associated with the endothelial cytoskele-
on and might contribute to intracellular O2•− production directly
Ray and Shah, 2005). Other Nox homologues are also expressed
n the arterial wall, with the dominant subtypes found in large
rteries being Nox2 and Nox4 in the endothelium and Nox1 and
ox4 in smooth muscle (Brandes and Schroder, 2008; Lassègue
nd Griendling, 2010). In contrast to Nox2, the Nox4 homologue
s constitutively active, localizes to the endoplasmic/sarcoplasmic
eticulum, generates H2O2 in preference to O2•−, and is insensitive
o apocynin because catalytic activity depends on Nox4/p22phox
ithout the requirement for p47phox and other proteins that
haracterizes the phagocytic complex (Brandes and Schroder,
008; Chen et al., 2008; Dikalov et al., 2008; Ray et al., 2011). The
resent ﬁndings therefore imply that the Nox4-based oxidase does
ot contribute to the potentiating effects of arsenite, as EDHF-type
elaxations were fully blocked by apocynin. While it has been
uggested that apocynin might act as an antioxidant rather than
n inhibitor of NADPH oxidase, the antioxidant effects were
etected only at 1 mM and were absent at the 100 M apocynin
oncentration employed in the present study (Heumuller et al.,
008).
.2. Differential effects of arsenite on EDHF-type and
O-mediated relaxations
Activation of endothelial NADPH oxidase should in theory
mpair NO-mediated arterial relaxations as a consequence of the
eaction between O2•− and NO (Grifﬁth et al., 1987), whose
xistence following exposure to arsenite has been inferred from
vidence of tissue protein nitrosation, presumably by peroxynitrite,
n endothelial cells (Straub et al., 2008). However, we  found that
rsenite did not affect aortic relaxations evoked by CPA and ACh,
ven though such responses were mediated exclusively by NO, and
rsenite was conﬁrmed to stimulate ROS production in the RAV
ndothelium. Furthermore, while arsenite potentiated EDHF-typeogy 306 (2013) 50– 58
relaxations, no evidence of potentiation was evident in the absence
of L-NAME/indomethacin. Taken together, these observations sug-
gest (i) that the ﬂux of NO generated by CPA or ACh substantially
exceeds the rate of formation of O2•− induced by arsenite in rabbit
endothelial cells, and (ii) that NO may  limit the availability of O2•−
for dismutation to H2O2, thereby compromising the ability of arse-
nite to potentiate any co-existent EDHF-type component of relax-
ation. Notably, we also demonstrated that arsenite did not enhance
ROS generation in the media of the RIA or aorta, and this is likely
to explain its inability to impair NO-mediated relaxation, despite
increased ROS production by the endothelium. In this regard it
should be noted that selective increases in endothelial O2•− pro-
duction also fail to impair NO-mediated aortic relaxations to ACh
or nitroprusside in transgenic mice with targeted endothelial over-
expression of Nox2 (Bendall et al., 2007), and that overexpression
of Nox4 in the endothelium, to increase intracellular production of
H2O2 (but not O2•−) may  enhance EDHF-type relaxations in trans-
genic mice without altering NO bioavailability (Ray et al., 2011). By
contrast, the well-documented ability of angiotensin II to depress
NO-mediated endothelium-dependent relaxation is accompanied
by a global increase in ROS production across the vessel wall sec-
ondary to dual activation of the Nox1-based smooth muscle oxidase
and the Nox2-based endothelial oxidase (Lassègue et al., 2001;
Touyz et al., 2002; Lassègue and Griendling, 2010). Angiotensin
II may  also stimulate ROS generation by vascular adventitial cells
(Pagano et al., 1997), whereas no evidence for excess arsenite-
induced adventitial DHE ﬂuorescence was  apparent in the present
study.
4.3. Relationship with previous studies
Previous reports have provided evidence that chronic in vivo
exposure to inorganic arsenic can impair subsequent ex vivo
endothelium-dependent relaxations to ACh in the rabbit and the
rat aorta (Pi et al., 2003; Verma et al., 2009). While these stud-
ies hypothesized that impaired NO-mediated relaxations reﬂected
overproduction of O2•−, the measurements made were indirect
(plasma [H2O2], nitrite and cGMP levels), and assessment of ROS
production in the vessel wall was  not attempted. Lee et al. (2003)
also observed apparent reductions in endothelium-dependent
relaxations to ACh in rat aortic rings exposed to 50 M arsenite for
14 h, but attributed these to impaired cGMP-mediated mechanisms
of relaxation and impaired conversion of L-arginine to L-citrulline
by eNOS, rather than increased ROS production. In view of these
conﬂicting observations, we  evaluated the effects of more pro-
longed 90 min  incubation with arsenite on both EDHF-type and
NO-mediated relaxation evoked by ACh in RIA rings. Notably, this
protocol reduced the contractile response to 1 M PE by ∼30%,
both in the presence or absence of L-NAME/indomethacin, with-
out greatly affecting the residual level of tone observed at the point
of maximal ACh-induced relaxation, so that standard analysis led
to an apparent decrease in Rmax, calculated on a % basis relative
to the initial level of pre-relaxation tone. However, pEC50 values
for the corresponding concentration–relaxation curves were not
affected by arsenite, and were essentially unchanged compared
to those obtained after exposure to 100 M arsenite for 30 min.
We observed a similar phenomenon in experiments where direct
smooth muscle relaxation was  elicited with MAHMA  NONOate
after constriction by 1 M PE and arsenite again reduced Rmax but
not pEC50 values. By contrast, when tone was  induced by 0.1 M PE,
to match the depressed constriction observed with 1 M PE in the
presence of arsenite, the reversal of tone by MAHMA  NONOate was
essentially complete. Taken together, such observations suggest
that apparent reductions in Rmax in the presence of arsenic primar-
ily reﬂect a generalized impairment of smooth muscle function,
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ather than speciﬁc effects against EDHF-type and NO-mediated
elaxations.
. Conclusion
The present study has identiﬁed complex effects of short-term
xposure to inorganic arsenic on EDHF-type and NO-mediated
rterial relaxations. An ability of arsenite to increase endothelial
roduction of H2O2 secondary to activation of NADPH oxidase
an potentiate EDHF-type responses, whereas selective increases
n endothelial O2•− production appeared insufﬁcient to impair
mooth muscle relaxations to endothelium-derived NO. Further
tudies are required to correlate in vitro observations with the
ong term vascular effects of arsenic ingestion in vivo at levels
ound in contaminated drinking water, and to clarify conﬂicting
eports that in vivo conversion to more toxic metabolites such as
onomethylarsonous acid that may  result in direct inhibition of
NOS (Vahter, 2002; Lee et al., 2003). Possible iatrogenic effects of
rivalent arsenic on vascular function also remain to be investigated
iven that arsenic trioxide is now widely used in the treatment of
aematological conditions such as acute promyelocytic leukaemia
Jing et al., 1999).
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